top of page

Search
All Posts


PMAC Welcomes Fred Hutchinson Cancer Center to Advance Global Precision Oncology
New York, NY — December 20, 2025 — PMAC (Precision Medicine Action for Cancer), a multi-insitutional academic consortium focused on accelerating the integration of precision medicine into oncology, is proud to announce that Fred Hutchinson Cancer Center (Fred Hutch) has officially joined as a participating institution. The addition of Fred Hutch, a world-renowned pioneer in cancer research and treatment, marks a significant expansion of the Consortium’s clinical and genom
Dec 20, 20252 min read
Precision Medicine Action for Cancer (PMAC) Announces Key New Liquid Biopsy Findings at the 2025 San Antonio Breast Cancer Symposium
New York, NY – December 9, 2025 – Precision Medicine Action for Cancer (PMAC), a newly formed non-profit organization dedicated to advancing precision medicine through liquid biopsy, today announced six abstract presentations at the 2025 San Antonio Breast Cancer Symposium. “Leveraging contributions from over 10 participating institutions , PMAC has established a robust resource: a clinically and molecularly annotated database featuring data from 3,000+ patients with breast
Dec 9, 20252 min read


Nov 14, 20250 min read


PMAC at SABCS 2025
We are excited to share that PMAC will be present at the San Antonio Breast Cancer Symposium (SABCS) 2025 with several impactful presentations. Connect with us at SABCS 2025 and share insights on advancing breast cancer research. Poster Spotlight 5 📍 December 11, 2025 | 7:00 AM–8:30 AM | Hemisfair 3 PD5-05 : Impact of circulating tumor DNA (ctDNA) surveillance on quality of life (QoL) for patients with early-stage breast cancer (EBC): prospective I-SURV study Presenter: C
Nov 1, 20252 min read


New Publication in npj Breast Cancer
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis
Read the full article here: https://www.nature.com/articles/s41523-025-00802-2
Aug 15, 20251 min read


PMAC at ASCO 2025
Join us at ASCO 2025 and connect with our team during the poster sessions. We look forward to engaging discussions and sharing insights on advancing breast cancer care.
May 22, 20251 min read


New Publication in JAMA Network Open
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer.
Read the full article here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2830759
Feb 3, 20251 min read
bottom of page